Search
for
Sort by
Research 541–570 of 613
- Targets to treat androgen excess in polycystic ovary syndrome
- POLYCYSTIC OVARY SYNDROME: DIAGNOSTIC CRITERIA AND TREATMENT METHODS
- Cardiometabolic risks in polycystic ovary syndrome: long-term population-based follow-up study
- Collagen, Diet, and Lifestyle Disorders: Interactions Across Metabolic, Cardiovascular, Skin, Joint, and Gut Health
- Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan
- Collagen, Diet, and Lifestyle Disorders: Interactions Across Metabolic, Cardiovascular, Skin, Joint, and Gut Health
- Metabolic aging and cutaneous markers of metabolic syndrome: a narrative review
- POLYCYSTIC OVARY SYNDROME: EXPLORING THE ICEBERG OF A LIFELONG SYSTEMIC DISORDER
- 268 Male-pattern baldness and its association with coronary heart disease
- Evaluation of hyperandrogenemia and metabolic risk profile in women with postadolescent acne
- Risk of Suicide, Hair Loss, and Aspiration with GLP1-Receptor Agonists and Other Diabetic Agents: A Real-World Pharmacovigilance Study
- Machine learning-based steroid metabolome analysis reveals three distinct subtypes of polycystic ovary syndrome and implicates 11-oxygenated androgens as major drivers of metabolic risk
- A practical guide on Polyendocrine Metabolic Ovarian Syndrome (PMOS) for Clinicians
- From PCOS to PMOS: The Impact of Physical Activity, Diet, and Metabolic Health on the Course of Polyendocrine Metabolic Ovarian Syndrome
- Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis
- Unusual patterns of presentation of frontal fibrosing alopecia: A clinical and trichoscopic analysis of 98 patients
- Muscle pain in a woman with congenital adrenal hyperplasia due to 21-hydroxylase deficiency resolved with testosterone therapy. A case report with 10 years of follow-up
- Ovarian Leydig cell tumor and postmenopausal hirsutism with signs of virilisation
- How should postmenopausal androgen excess be evaluated?
- Evaluation of periodontal health among patients with polycystic ovarian syndrome a cross sectional study
- Development and validation of a method for simultaneous determination of hair glucocorticoids and endocannabinoids as biomarkers of stress during pregnancy
- Progressive Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) from a Young Age Due to a Rare Genetic Disorder, Familial Partial Lipodystrophy: A Case Report and Review of the Literature
- Vitamin D deficiency in patients with alopecia areata: A systematic review and meta-analysis
- Postmenopausal ovarian hyperandrogenism of surgically treated patients: a case report and scoping review with individual patient’s data analysis
- Modern approaches to the diagnosis and treatment of polycystic ovary syndrome in adolescence
- 5α-Reductase Type 2 Regulates Glucocorticoid Action and Metabolic Phenotype in Human Hepatocytes
- The treatment of polycystic ovary syndrome.
- Post-COVID-19 Sydrome and Decrease in Health-Related Quality of Life in Kidney Transplant Recipients after SARS-COV-2 Infection—A Cohort Longitudinal Study from the North of Poland
- PCOS and Cardiometabolic Health over the Reproductive Years
- Differential cardiometabolic outcomes of leuprolide versus spironolactone in women with polycystic ovary syndrome